Nephoxil capsule safety study for kidney dialysis patients
Part of Hormones & metabolism clinical trials.
This study follows kidney dialysis patients who are starting a new medicine called Nephoxil to lower high phosphorus levels in the blood. The study will check how safe and effective the medicine is over 48 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years of age or older.
- You have chronic kidney disease and are on hemodialysis (a treatment that filters your blood).
- You are about to take Nephoxil for the first time for high phosphorus levels, as decided by your doctor.
- You agree to take part in the study and sign a consent form.
- You are not taking any aluminum-containing medicines.
- You do not have any condition that prevents you from taking Nephoxil according to its approved label.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, JMKX003002, to lower high phosphorus levels in people with end-stage kidney disease who are on hemodialysis. If you have trouble controlling your phosphorus, this treatment might help.
This trial tests a new medication called AP306 for people on hemodialysis who have high blood phosphate. It aims to see if the drug is safe, tolerable, and helps lower phosphate levels.
This trial compares two treatment goals for blood phosphate levels in people with end-stage kidney disease who are on dialysis. It may help determine which target is safer and works better in real-world care.
This trial tests a new drug called AP301 to lower high phosphate levels in people on dialysis. It's designed to help control phosphate, which can be hard to manage with diet and current medications.
This study tests an investigational drug called KK8123 for adults with X-linked hypophosphatemia (XLH), a rare condition that causes low phosphate levels and can lead to bone problems. The goal is to see if it helps improve phosphate levels in the body.
This trial tests a single dose of the study drug hydroxynidone in people with different levels of kidney function, including healthy volunteers and those with kidney disease. The goal is to learn how the drug works in the body when kidneys are not working normally.
Hear when a new Hyperphosphatemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.